Enovis Corporation (ENOV)

NYSE: ENOV · IEX Real-Time Price · USD
66.69
3.25 (5.12%)
May 17, 2022 3:59 PM EDT - Market closed
Market Cap3.60B
Revenue (ttm)4.00B
Net Income (ttm)67.65M
Shares Out54.03M
EPS (ttm)1.37
PE Ratio48.75
Forward PE13.21
Dividendn/a
Ex-Dividend Daten/a
Volume395,102
Open64.97
Previous Close63.44
Day's Range64.80 - 66.85
52-Week Range59.15 - 94.10
Beta2.12
AnalystsBuy
Price Target140.35 (+110.5%)
Earnings DateMay 10, 2022

About ENOV

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therap...

IndustrySpecialty Industrial Machinery
IPO DateMay 8, 2008
CEOMatthew Trerotola
Employees16,200
Stock ExchangeNYSE
Ticker SymbolENOV
Full Company Profile

Financial Performance

In 2021, Enovis's revenue was $3.85 billion, an increase of 25.52% compared to the previous year's $3.07 billion. Earnings were $71.66 million, an increase of 68.11%.

Financial Statements

Analyst Forecast

According to 15 analysts, the average rating for ENOV stock is "Buy." The 12-month stock price forecast is 140.35, which is an increase of 110.45% from the latest price.

Price Target
$140.35
(110.45% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Enovis (ENOV) Tops Q1 Earnings and Revenue Estimates

Enovis (ENOV) delivered earnings and revenue surprises of 8.82% and 177.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

Enovis Announces First Quarter 2022 Adjusted Stand Alone Results

Wilmington, DE, May 10, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, today announced its adjuste...

1 week ago - GlobeNewsWire

New Strong Sell Stocks for May 5th

ENOV, FFIV, and CABGY have been added to the Zacks Rank #5 (Strong Sell) List on May 5, 2022

Other symbols:FFIV
1 week ago - Zacks Investment Research

Analysts Estimate Enovis (ENOV) to Report a Decline in Earnings: What to Look Out for

Enovis (ENOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

Enovis Schedules First Quarter 2022 Earnings Release and Conference Call

Wilmington, DE, April 14, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, today announced that it w...

1 month ago - GlobeNewsWire

Enovis (formerly Colfax) Completes Spin-off of ESAB Corporation

Wilmington, DE, April 05, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (“Enovis” or the “Company”) (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporatio...

1 month ago - GlobeNewsWire

ESAB Set to Join S&P MidCap 400; PROG Holdings to Join S&P SmallCap 600

NEW YORK , March 30, 2022 /PRNewswire/ -- ESAB Corp. (NYSE: ESAB) will be added to the S&P MidCap 400 effective prior to the opening of trading on Tuesday, April 5. Effective prior to the opening of tra...

Other symbols:ESABPRGSPGI
1 month ago - PRNewsWire

Colfax Announces Board of Directors for Post-Spinoff ESAB

Wilmington, DE, March 28, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company which will renamed Enovis Corporation (“Enovis”) following the expected April ...

1 month ago - GlobeNewsWire

Why Is Colfax (CFX) Down 4.2% Since Last Earnings Report?

Colfax (CFX) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

KeyBanc, Morgan Stanley Slash Price Target On Colfax

Colfax Corp's (NYSE: CFX) price target has been lowered to $52 (an upside of 41%) from $60 by KeyBanc analyst Jeffrey Hammond, following ESAB/Enovis's 2022 Investor Day to reflect broadly lower peer mul...

2 months ago - Benzinga

Colfax Announces Expected Completion Date of April 4, 2022 for Spin-Off of ESAB Corporation

Wilmington DE,, March 14, 2022 (GLOBE NEWSWIRE) -- —Colfax Corporation (“Colfax”) (NYSE: CFX) today announced that its Board of Directors has declared (a) a pro rata distribution of 90% of the outstandi...

2 months ago - GlobeNewsWire

Colfax Announces Board of Directors for Enovis, the Post-Spinoff Medical Technology Company

Wilmington DE,, March 11, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced the future composition of the Board of Directors (the “Board”...

2 months ago - GlobeNewsWire

Colfax Announces Conditional Redemption of its 3.250% Senior Notes due 2025 and its 6.375% Senior Notes due 2026

Wilmington, DE, March 07, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it had given notice of its i...

2 months ago - GlobeNewsWire

Colfax (CFX) Q4 Earnings & Revenues Surpass Estimates, Up Y/Y

Colfax's (CFX) fourth-quarter 2021 net sales increase 23.6% year over year on impressive performance across its segments.

2 months ago - Zacks Investment Research

Colfax (CFX) Beats Q4 Earnings and Revenue Estimates

Colfax (CFX) delivered earnings and revenue surprises of 3.51% and 2.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

DJO® Showcases Growing Foot & Ankle Portfolio at ACFAS Scientific Conference

DALLAS--(BUSINESS WIRE)-- #acfas--DJO®, a leading global provider of medical technologies, announced it will showcase their growing Foot & Ankle offerings at ACFAS 2022.

2 months ago - Business Wire

Colfax Corporation Announces Fourth Quarter and Full Year 2021 Results

Wilmington, DE, Feb. 22, 2022 (GLOBE NEWSWIRE) --  Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the fourth quarter and fiscal year ...

2 months ago - GlobeNewsWire

Colfax (CFX) Exhibits Strong Prospects, Headwinds Persist

Colfax (CFX) is poised to benefit from its exposure in diverse end markets, acquired assets and solid demand for its products. However, rising costs and high debt levels remain concerns.

2 months ago - Zacks Investment Research

Colfax (CFX) Earnings Expected to Grow: Should You Buy?

Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Colfax Schedules Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call

Wilmington DE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results ...

3 months ago - GlobeNewsWire

Colfax's (CFX) Product Strength Aids Amid Cost & Supply Woes

Colfax (CFX) benefits from solid product offerings and focus on innovation, healthy demand and acquisition synergies. Cost inflation and supply-chain woes are concerning.

4 months ago - Zacks Investment Research

Colfax to Present at the 40th Annual JP Morgan Healthcare Conference

Wilmington, DE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, announced today that it will be presenting at the J.P. Morgan Healthcare Confe...

4 months ago - GlobeNewsWire

Loop Capital Is Bullish On Lincoln Electric; Initiates Colfax With Hold

Loop Capital analyst Chris Dankert initiated coverage of two Machinery companies.

Other symbols:LECO
4 months ago - Benzinga

Colfax Announces Plans for Reverse Stock Split

WILMINGTON, DE, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it plans to hold a special me...

4 months ago - GlobeNewsWire

Colfax (CFX) Meets Earnings Estimates in Q3, Lowers View

Colfax's (CFX) Q3 earnings reflect the impacts of improved sales, margin expansion, supply-chain woes and logistics issues. For 2021, it lowers earnings projections on high taxes and pandemic woes.

6 months ago - Zacks Investment Research